BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Siroen MP, Wiest R, Richir MC, Teerlink T, Rauwerda JA, Drescher FT, Zorger N, Leeuwen PAV. Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients. World J Gastroenterol 2008; 14(47): 7214-7219 [PMID: 19084936 DOI: 10.3748/wjg.14.7214]
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7214.htm
Number Citing Articles
1
Daniela Campion, Felice Rizzi, Silvia Bonetto, Ilaria Giovo, Michele Roma, Giorgio M. Saracco, Carlo Alessandria. Assessment of glomerular filtration rate in patients with cirrhosis: Available tools and perspectivesLiver International 2022; 42(11): 2360 doi: 10.1111/liv.15198
2
Balasubramaniyan Vairappan. Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressWorld Journal of Hepatology 2015; 7(3): 443-459 doi: 10.4254/wjh.v7.i3.443
3
Mohammad A. Aboul-Ezz, Ali Abdel Rahim, Ahmed El-Mikkawy, Mohammad A. Elkady, Mohamed. A Elrefaiy, Samia El-Shishtawy, Osama Mosbah, Khaled Mabrouk, Mostafa Elshafie, Omar M. Sabry. Hepatorenal Syndrome: A Way for Early and Accurate DiagnosisOpen Access Macedonian Journal of Medical Sciences 2022; 10(B): 1979 doi: 10.3889/oamjms.2022.9675
4
Daniel Benten, Julian Schulze zur Wiesch, Karsten Sydow, Andreas Koops, Peter Buggisch, Rainer H Böger, Charlotte A Gaydos, Helen Won, Veronica Franco, Ansgar W Lohse, Stuart C Ray, Ashwin Balagopal. The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).BMC Gastroenterology 2011; 11(1) doi: 10.1186/1471-230X-11-107
5
Jasmohan S. Bajaj, Vishwadeep Ahluwalia, James B. Wade, Arun J. Sanyal, Melanie B. White, Nicole A. Noble, Pamela Monteith, Michael Fuchs, Richard K. Sterling, Velimir Luketic, Iliana Bouneva, Richard T. Stravitz, Puneet Puri, Kenneth A. Kraft, HoChong Gilles, Douglas M. Heuman. Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosisJournal of Hepatology 2013; 58(1): 38 doi: 10.1016/j.jhep.2012.08.005
6
da Silva Robin P, Eudy Brandon J, Deminice Rafael. One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them AllThe Journal of Nutrition 2020; 150(5): 994 doi: 10.1093/jn/nxaa032
7
Jiunn-Ming Sheen, Yu-Chieh Chen, You-Lin Tain, Li-Tung Huang. Increased Circulatory Asymmetric Dimethylarginine and Multiple Organ Failure: Bile Duct Ligation in Rat as a ModelInternational Journal of Molecular Sciences 2014; 15(3): 3989 doi: 10.3390/ijms15033989
8
Anna Czarnecka, Krzysztof Milewski, Magdalena Zielińska. Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?Neurochemical Research 2017; 42(3): 750 doi: 10.1007/s11064-016-2111-x
9
Kristina Eisinger, Sabrina Krautbauer, Reiner Wiest, Thomas Karrasch, Yvonne Hader, Marcus N. Scherer, Stefan Farkas, Charalampos Aslanidis, Christa Buechler. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertensionEuropean Journal of Clinical Investigation 2013; 43(9): 926 doi: 10.1111/eci.12122
10
Murat Celik, Hilmi Umut Unal. L-Arginine in Clinical Nutrition2017; : 225 doi: 10.1007/978-3-319-26009-9_18
11
Krzysztof Milewski, Wojciech Hilgier, Jan Albrecht, Magdalena Zielińska. The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidineNeurochemistry International 2015; 88: 26 doi: 10.1016/j.neuint.2014.12.004
12
Maro Dragičević, Iva Košuta, Egon Kruezi, Marijana Vučić Lovrenčić, Anna Mrzljak. Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver DiseaseMedicina 2020; 56(11): 622 doi: 10.3390/medicina56110622
13
Ayse L. Mindikoglu, Thomas C. Dowling, Laurence S. Magder, Robert H. Christenson, Matthew R. Weir, Stephen L. Seliger, William R. Hutson, Charles D. Howell. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and DimethylargininesClinical Gastroenterology and Hepatology 2016; 14(4): 624 doi: 10.1016/j.cgh.2015.06.021
14
Ayse L. Mindikoglu, Stephen C. Pappas. New Developments in Hepatorenal SyndromeClinical Gastroenterology and Hepatology 2018; 16(2): 162 doi: 10.1016/j.cgh.2017.05.041
15
Reiner Wiest, Thomas S. Weiss, Lusine Danielyan, Christa Buechler. Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot StudyJournal of Clinical Medicine 2021; 10(12): 2669 doi: 10.3390/jcm10122669
16
Sabrina Krautbauer, Kristina Eisinger, Reiner Wiest, Gerhard Liebisch, Christa Buechler. Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosisProstaglandins & Other Lipid Mediators 2016; 124: 27 doi: 10.1016/j.prostaglandins.2016.06.001